Navigation Links
Cardium Reports on First Quarter 2008 Highlights and Financial Results
Date:5/9/2008

nge Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2008 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit http://www.cardiumthx.com.

Cardium Therapeutics(TM), Corgentin(TM) and Generx(TM) are trademarks of
Cardium Therapeutics, Inc. Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM) and Excellarate(TM) are
trademarks of the Tissue Repair Company.

InnerCool Therapies(R), InnerCool(R), Celsius Control System(TM),

Accutrol(TM), CoolBlue(TM) and RapidBlue(TM)

are trademarks of InnerCool Therapies, Inc.

- Continued -

Cardium Therapeutics, Inc.

Three Months Ended

March 31,

(Unaudited)

Selected Condensed 2008 2007

Consolidated

Operational Results

Revenues $646,002 $309,331

Cost of goods sold (370,696) (246,565)

Gross profit 275,306 62,766

Research and development 3,372,480 3,242,866

Selling, general and

administrative 3,385,566 2,539,101

Amortization - Intangibles 197,414 207,043

Loss from operations (6,680,154) (5,926,244)

Interest income (expense), net (53,974) 86,395

Net loss
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
2. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
3. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
5. Cardium Completes $5.3 Million Registered Direct Offering
6. Cardium Announces $5.3 Million Registered Direct Offering
7. Novavax Reports First Quarter 2008 Financial Results
8. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
9. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
10. Pharmos Corporation Reports 2008 First Quarter Results
11. Halozyme Therapeutics Reports 2008 First Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstC... ), a leading provider of tools and services for d...troduced Living Image 4.0 software for IVIS® ...ves the more than 800 Caliper IVIS systems current...ge 4.0 features advanced spectral unmixing tools t...
(Date:12/2/2009)... , COLUMBIA, Md., Dec. 2 /PRNewswire-FirstCall... ) announced today that it intends to release the ... on December 16, 2009, at approximately 4:00 p.m. ... p.m. ET Martek will conduct a conference call to ...ted parties may listen to the call live via webcas...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Neurost...tp://www.reportlinker.com/p0164232/Neurostimulatio...orld neurostimulation market stands enthused by th...ant rise in age-related diseases such as, Parkinso...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Drug Di...rends & Opportunities ,, http://www.repor...-A-Global-Update-of-Market-Trends--Opportunities.h...nd ongoing element of every pharmaceutical company...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
...an. 28 /PRNewswire-FirstCall/ - Quest PharmaTech I...t it has signed a,collaborative research agreement... a combination therapy for the treatment of lung c...mpany,s lead oncology product,SL052, with various ...photodynamic therapy (PDT) can augment the therape...
...N.J., Jan 28 Phytomedics Inc., a clinical,stage b...mponent /,multi-targeted drug products, announced ...althcare Conference in Boston, Massachusetts on We... topics of the presentation will be an overview of...ents, including Phase III development,activities r...
...x(TM) Platform Accurately Mimics a Human Capillary...national,provider of microfluidic systems in the e...y its worldwide launch of its VenaFlux(TM),Platfor...h throughput,microfluidic cell- based assay system...othelial- cell cultured microchannels, producing I...
Other Biology Technology:Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3Cellix Ltd. Launches the First Semi-Automated, High Throughput Cell-Adhesion Assay Platform 2
(Date:12/3/2009)...n it comes to investment in energy efficient techn...ences Research Council (EPSRC) Chief Executive Dav...and engineering research has already brought us fu...but more investment is needed to develop the capab...ur carbon emission targets by 2020 and limit the i...
(Date:12/2/2009)...results strengthen the evidence that people who sm...increased risk for developing colorectal cancer, e...This provides one more reason not to smoke, or to ...ael J. Thun, M.D., M.S., vice president emeritus, ...ican Cancer Society. "Colorectal cancer should be ...
(Date:12/2/2009)... a cancer-free status did not prompt people partic...) lung-cancer screening program to pick up their c...ished in Cancer Epidemiology, Biomarkers & Preven...ancer Research. The December issue contains a spec...gate widespread concern in the lung screening comm...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Cigarette smoking increases colorectal cancer risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Statins May Worsen Fatigue in Heart Failure Patients 60606 1Statins May Worsen Fatigue in Heart Failure Patients 60606 2Statins May Worsen Fatigue in Heart Failure Patients 60606 3Sun or shade 3A Pecan leaves photosynthetic light response evaluated 10611 1Sun or shade 3A Pecan leaves photosynthetic light response evaluated 10611 2A Breast Cancer Test That Saves Lives 60601 1A Breast Cancer Test That Saves Lives 60601 2A Breast Cancer Test That Saves Lives 60601 3
...ransform the dead bone of a transplanted skeletal ...g mice. The advance, which uses gene therapy to st...as living bone, is a promising development for the... who suffer with fragile and failing bone grafts. ...ppear in the March 1 issue of Nature Medicine. , ...
...ve been,viewed as the real movers and shakers in g...a messenger that shuttles information between the,...Biomedical Research,and Massachusetts Institute of...es called microRNAs regulate thousands of human ge...oding regions. In other words,a class of molecule...
...oomberg School of Public Health are exploring ways...s using genetically modified adenoviruses, a commo... vaccines have long been proven to be safe and eff...constructing a replicating live recombinant adenov...rovide longer-lasting disease protection, which wo...
Other Biology News:Gene therapy converts dead bone graft to new, living tissue 2Gene therapy converts dead bone graft to new, living tissue 3Gene therapy converts dead bone graft to new, living tissue 4NYU researchers simulate molecular biological clock 2Live Recombinant Adenovirus Vaccine Technique Explored 2
...ser Capture Microdissection (LCM) is the method of...ritas Microdissection is the only instrument to of...d flexibility., UV Laser Cutting provides ...n-soft tissues and capturing large numbers of cell...
Hybridizer (220 V) from Dako
...e NanoChip 400 System is an automated multiplexing... for performing SNP detection, pathogen sequence d...le samples with multiple targets can be applied to...anoChip cartridge, which may be reused until all t...
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Biology Products: